Natural killer cell cytotoxicity and alpha-interferon in early rheumatoid arthritis. 1993

H G Taylor, and N B Nixon, and P T Dawes
Staffordshire Rheumatology Centre, Haywood Hospital, Stoke-on-Trent, UK.

Natural killer (NK) cell number, cytotoxicity, and serum alpha-interferon (alpha-IFN) was measured in a group of early synovitis patients and compared to that of established rheumatoid arthritis patients and normal controls. No significant differences in NK cell number or serum alpha-IFN were found. NK cell cytotoxicity (NKCC) in the early synovitis group was significantly (p < 0.05) reduced compared to that of the normal controls and not significantly different from the established rheumatoid controls. There was a trend for those early synovitis patients with a good outcome to have higher NKCC. Low NKCC is evident very early in the course of rheumatoid arthritis and is thus unlikely to be secondary to chronic inflammation. There is no relationship between NKCC and alpha-IFN levels and the cause of the reduced NKCC is unknown. Alpha-IFN levels are not raised early in the course of RA.

UI MeSH Term Description Entries
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis

Related Publications

H G Taylor, and N B Nixon, and P T Dawes
April 1985, Acta pathologica, microbiologica, et immunologica Scandinavica. Section C, Immunology,
H G Taylor, and N B Nixon, and P T Dawes
January 1988, Yonsei medical journal,
H G Taylor, and N B Nixon, and P T Dawes
January 1986, Clinical and experimental rheumatology,
H G Taylor, and N B Nixon, and P T Dawes
July 1984, Clinical immunology and immunopathology,
H G Taylor, and N B Nixon, and P T Dawes
January 1990, Natural immunity and cell growth regulation,
H G Taylor, and N B Nixon, and P T Dawes
August 1993, The American journal of physiology,
H G Taylor, and N B Nixon, and P T Dawes
October 2008, The Journal of rheumatology,
H G Taylor, and N B Nixon, and P T Dawes
September 1990, Cancer research,
H G Taylor, and N B Nixon, and P T Dawes
August 1993, Journal of interferon research,
Copied contents to your clipboard!